Article Details

Eylea data gives Regeneron/Bayer a lift in ophthalmic diseases - - Pharmaphorum

Retrieved on: 2022-09-09 08:20:39

Tags for this article:

Click the tags to see associated articles and topics

Eylea data gives Regeneron/Bayer a lift in ophthalmic diseases - - Pharmaphorum. View article details on hiswai:

Excerpt

Meanwhile, all the drugs for AMD and DME are expected to be squeezed by lower-cost, biosimilar versions of Novartis and Roche's Lucentis (ranibizumab) ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up